Mohedas, A., Wang, Y., Sanvitale, C., Canning, P., Choi, S., Xing, X., . . . Yu, P. (2014). Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
Чикаго стиль цитування (17-те видання)Mohedas, A., Y. Wang, C. Sanvitale, P. Canning, S. Choi, X. Xing, A. Bullock, G. Cuny, та P. Yu. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.
Стиль цитування MLA (9-ме видання)Mohedas, A., et al. Structure-activity Relationship of 3,5-diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. 2014.